EORTC – European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:
“This Men’s Health Awareness Week, we’re proud to mark the official launch of the DE-ESCALATE Project, a pragmatic Phase III clinical trial focusing on metastatic prostate cancer.
DE-ESCALATE is one of three research projects coordinated by EORTC, alongside the LEGATO Project and the STREXIT 2 Project, which have received funding from the Horizon Europe Programme. The study is in collaboration with Syreon Research Institute and will have a duration of five years.
Read the article to learn more.”
More posts featuring EORTC.